NCT01299584 - ULTIVA Post Marketing Surveillance | Biotech Hunter

Enrollment

775

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions

Analgesia

Interventions

DRUG

Remifentanil

Basically there is no treatment allocation. Subjects who would be administered of remifentanil at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.